Canada markets open in 50 minutes

XORTX Therapeutics Inc. (XRTX.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
3.5000+0.1400 (+4.17%)
At close: 09:30AM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 10.16M
Enterprise Value 4.93M
Trailing P/E 1.49
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.97
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.12

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-95.40%
S&P500 52-Week Change 323.49%
52 Week High 389.9100
52 Week Low 32.6500
50-Day Moving Average 34.0644
200-Day Moving Average 319.0678

Share Statistics

Avg Vol (3 month) 314.08k
Avg Vol (10 day) 32.03k
Shares Outstanding 52.9M
Implied Shares Outstanding 62.9M
Float 82.21M
% Held by Insiders 14.82%
% Held by Institutions 19.33%
Shares Short (May 15, 2024) 49.35k
Short Ratio (May 15, 2024) 42.1
Short % of Float (May 15, 2024) 40.33%
Short % of Shares Outstanding (May 15, 2024) 40.32%
Shares Short (prior month Apr 15, 2024) 49.79k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:9
Last Split Date 3Nov 14, 2023

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-31.00%
Return on Equity (ttm)-57.92%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -3.86M
Net Income Avi to Common (ttm)-3.34M
Diluted EPS (ttm)-1.8900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.84M
Total Cash Per Share (mrq)1.58
Total Debt (mrq)14.04k
Total Debt/Equity (mrq)0.56%
Current Ratio (mrq)13.68
Book Value Per Share (mrq)1.02

Cash Flow Statement

Operating Cash Flow (ttm)-5.4M
Levered Free Cash Flow (ttm)-2.96M